Status
Founded
Development stage
Cambridge RNA Technologies is developing long-term RNAs (ltRNAs) - engineered RNA molecules that persist for weeks or months rather than hours. By combining the safety of RNA with durability previously only achievable through genome modification, ltRNAs enable durable therapeutic gene expression for protein replacement, immune cell engineering, and regenerative medicine without the risks of permanent genomic changes.